Is a complete STOK research report available?

No complete published report is available for Stoke Therapeutics, Inc. (STOK) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · USD

$29.5

+0.09 (+0.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first STOK analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.8B
Revenue (ttm)	32.1M
Net income (ttm)	-169.8M
EPS (ttm)	-$2.81
Shares out	62.3M
Volume	700,137
Beta	1.18
Price target	$45.8	+55.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 32.1M
Net income (ttm): -169.8M
EPS (ttm): -$2.81
Market cap: 1.8B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All STOK indicators

Market & fundamental data

Available fields

213

Groups with data

Currency

USD

Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001623526
Company name	Stoke Therapeutics, Inc.
Country	United States
Country code	US
Cusip	86150R107
Employees	170
Employees Change	42%
Employees Change Percent	32.81
Enterprise value	$1.4B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-06-19
Isin	US86150R1077
Last refreshed	2026-07-30
Market cap	$1.8B
Market cap category	Small-Cap
Price	$29.48
Price currency	USD
Rev Per Employee	188,705.88x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	STOK
Website	https://www.stoketherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.25%
EV Sales Forward	69.23x
EV/Sales	44.53x
FCF yield	-8.04%
P/B ratio	4.65x
P/S ratio	57.23x
PS Forward	88.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-577.46%
EBITDA Margin	-572.06%
Gross margin	100%
Gross Profit	$32.1M
Gross Profit Growth	-83.2%
Gross Profit Growth Q	-96.07%
Gross Profit Growth3 Y	30.13%
Net Income	$-169.8M
Net Income Growth Years	2%
Pretax Margin	-533.18%
Profit Per Employee	$-998,629
ROA	-27.24
Roa5y	-21.02
ROCE	-46.03
ROE	-45.58
Roe5y	-38.65
ROIC	-292.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	130.26%
Cagr3y	66.98%
Cagr5y	-0.35%
EPS Growth Years	3
Revenue Growth	-83.2x
Revenue Growth Q	-96.07x
Revenue Growth Years	2x
Revenue Growth3 Y	30.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.08
Assets	$443.3M
Cash	$343.5M
Current Assets	$366.7M
Current Liabilities	$40.8M
Debt	$3.4M
Debt Equity	$0.01
Equity	$394.9M
Interest Coverage	-5,975.7
Liabilities	$48.4M
Long Term Assets	$76.6M
Long Term Liabilities	$7.6M
Net Cash	$407.6M
Net Cash By Market Cap	$22.2
Net Cash Growth	8.38%
Net Debt Equity	$-1.03
Tangible Book Value	$394.9M
Tangible Book Value Per Share	$6.34
WACC	10.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.99
Net Working Capital	$-15.2M
Quick ratio	8.57
Working Capital	$325.9M
Working Capital Turnover	$0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.62%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	130.13%
200-day SMA	31.66
3Y total return	365.72%
50-day SMA	30.31
50-day SMA vs 200-day SMA	50under200
5Y total return	-1.73%
All Time High	71.58
All Time High Change	-58.82%
All Time High Date	2021-01-20
All Time Low	3.35
All Time Low Change	780%
All Time Low Date	2023-10-27
ATR	1.54
Beta	1.18
Beta1y	1.02
Beta2y	1.56
Ch YTD	-7.12
High	30.11
High52	40.22
High52 Date	2026-03-10
High52ch	-26.7%
Low	28.83
Low52	12.25
Low52 Date	2025-07-29
Low52ch	140.65%
Ma50ch	-2.73%
Premarket Change Percent	-0.31
Premarket Price	$29.3
Premarket Volume	307
Price vs 200-day SMA	-6.89%
RSI	45.51
RSI Monthly	60.67
RSI Weekly	46.88
Sharpe ratio	1.56x
Sortino ratio	2.81
Total Return	-5.62%
Tr YTD	-7.12
Tr1m	-7.87%
Tr1w	1.8%
Tr3m	-11.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	13
Analyst Count Top	9
Analyst Price Target Top	$46.71
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.78
Earnings Revenue Estimate	5,383,640x
Earnings Revenue Estimate Growth	-61.04x
Operating Income	$-185.2M
Operating margin	-577.5
Price target	$45.82
Price Target Change	$55.43
Price Target Change Top	$58.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46,768,137%
Float Percent	75.09%
Shares Insiders	3.84%
Shares Institutions	94.24%
Shares Out	62,281,655
Shares Qo Q	1.65%
Shares Yo Y	5.62%
Short Float	33.55%
Short Ratio	14.65
Short Shares	25.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-181.9M
Adjusted OCF	-181,062,000
Average Volume	650,264.2x
Bv Per Share	6.34
CAPEX	$-871,000
Ch1m	-7.87
Ch1w	1.8
Ch1y	130.1
Ch3m	-11.55
Ch3y	365.7
Ch5y	-1.73
Ch6m	0.27
Change	0.31%
Change From Open	0.17
Close	29.39
Days Gap	0.14
Depreciation Amortization	1,732,000
Dollar Volume	20,640,038.8
Earnings Date	2026-08-03
Earnings Time	amc
EBIT	$-185.2M
EBITDA	$-183.5M
EPS	$-2.81
F Score	2
FCF	$-147.7M
FCF EV Yield	-10.34x
FCF Per Share	$-2.37
Financing CF	180,342,000
Fiscal Year End	December
Founded	2,014
Income Tax	$-1.3M
Investing CF	-149,750,000
Ipr	63.78
Iprfo	8.34
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-16
Ma150	32.15
Ma150ch	-8.3%
Ma20	30.35
Ma20ch	-2.86%
Net CF	-116,232,000
Next Earnings Date	2026-08-03
Open	29.43
Optionable	Yes
Position In Range	50.78
Post Close	29.48
Postmarket Change Percent	-0.75
Postmarket Price	$29.26
Ppne	5,888,000
Pre Close	29.39
Price Date	2026-07-29
Ptbv Ratio	4.65
Relative Volume	1.08x
Revenue	32,080,000x
SBC By Revenue	106.73x
Share Based Comp	34,238,000
Tax By Revenue	-3.98x
Tr6m	0.27%
Us State	Massachusetts
Volume	700,137
Z Score	13.42

Stoke Therapeutics, Inc. (STOK)

Coverage state: Market snapshot only — no published research

Generate the first STOK analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · STOK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All STOK indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on STOK

Frequently asked questions